BERZIGOTTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 2.647
EU - Europa 1.824
AS - Asia 1.096
AF - Africa 95
SA - Sud America 13
OC - Oceania 4
Totale 5.679
Nazione #
US - Stati Uniti d'America 2.640
GB - Regno Unito 436
CN - Cina 335
IT - Italia 261
DE - Germania 252
SG - Singapore 239
SE - Svezia 230
VN - Vietnam 227
HK - Hong Kong 163
RU - Federazione Russa 107
UA - Ucraina 104
IN - India 91
IE - Irlanda 81
FR - Francia 76
NL - Olanda 72
CH - Svizzera 58
EE - Estonia 37
ZA - Sudafrica 36
TG - Togo 28
FI - Finlandia 26
BG - Bulgaria 24
CI - Costa d'Avorio 20
AT - Austria 11
KR - Corea 11
BE - Belgio 10
HR - Croazia 10
BR - Brasile 8
GR - Grecia 7
JO - Giordania 7
JP - Giappone 7
CA - Canada 6
CZ - Repubblica Ceca 5
AU - Australia 4
ES - Italia 4
IR - Iran 4
LB - Libano 4
NG - Nigeria 4
PL - Polonia 4
SC - Seychelles 4
LT - Lituania 3
PT - Portogallo 3
TR - Turchia 3
EG - Egitto 2
ID - Indonesia 2
AR - Argentina 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.679
Città #
Southend 377
Fairfield 317
Chandler 316
Singapore 199
Santa Clara 188
Ashburn 186
Hong Kong 160
Seattle 142
Woodbridge 142
Houston 131
Wilmington 125
Dong Ket 123
Cambridge 108
Princeton 95
Dublin 81
Ann Arbor 78
Boardman 61
Jacksonville 58
Bern 55
Nanjing 43
Westminster 39
Bologna 38
Bremen 34
Padova 34
Lomé 28
Milan 26
San Diego 26
Helsinki 25
Sofia 24
Shenyang 22
Berlin 21
Jinan 21
Saint Petersburg 21
Abidjan 20
Florence 20
Munich 18
Nanchang 18
Hanoi 17
Turin 17
Hefei 16
Ho Chi Minh City 16
Beijing 15
Medford 14
New York 14
Tianjin 14
Hebei 13
Redwood City 13
Des Moines 12
Frankfurt am Main 12
Rome 12
Changsha 11
Seoul 11
Brussels 10
Los Angeles 10
Dearborn 9
Guangzhou 9
Kyiv 9
London 9
Mülheim 9
Ningbo 8
Amman 7
Düsseldorf 7
Falkenstein 7
Taiyuan 7
Tokyo 7
Vienna 7
Chicago 6
Kuban 6
Nuremberg 6
Paris 6
Shanghai 6
Bühl 5
Haiphong 5
Jiaxing 5
Lauterbourg 5
Norwalk 5
Phoenix 5
Verona 5
Zhengzhou 5
Abeokuta 4
Haikou 4
Hangzhou 4
Kunming 4
Mahé 4
Pune 4
Taizhou 4
Toronto 4
Yubileyny 4
Amsterdam 3
Bexley 3
Da Nang 3
Falls Church 3
Fuzhou 3
Hyderabad 3
Mountain View 3
Naples 3
Olalla 3
Portsmouth 3
Suzhou 3
São Paulo 3
Totale 3.884
Nome #
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 192
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 189
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 158
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 151
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 146
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 145
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 144
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 141
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 140
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 137
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 135
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 134
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 131
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 130
Routine blood tests? Helping you live(r) longer! 129
Renovascular impedance correlates with portal pressure in patients with liver cirrhosis 128
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 127
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 127
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 127
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 118
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 118
Effetti dell’allenamento aerobico sui fattori di rischio cardiovascolare e sullo stato cognitivo dell’anziano 116
Prevalence and factors associated with fatty liver in a geriatric population: results from the Pianoro Study. 115
null 115
New abdominal collaterals at ultrasound: a clue of progression of portal hypertension 114
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 113
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version) 113
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic eraThe views of a panel of worldwide international experts 113
Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis 112
Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. 111
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. 107
Systemic endothelial function evaluated by flow-mediated dilatation of brachial artery in patients with liver disease 106
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) 105
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis 105
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 100
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience 98
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS 94
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 93
null 88
Natural history of formation and growth of oesophageal varices 85
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 79
Torsade de pointes during amiodarone infusion in a cirrhotic patient with a prolonged QT interval. 72
null 71
Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of hematocrit and hepatic steatosis. 67
Splanchnic hemodynamics in non-alcoholic fatty liver disease: effect of a dietary/ pharmachological treatment. A pilot study 64
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 56
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper 55
null 54
Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges 46
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 42
Isolated hepatic tuberculoma after orthotopic liver transplantation: a case report 42
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 41
Inter‐Reader Agreement for Contrast‐Enhanced Ultrasound Liver Imaging Reporting and Data System Major Features and Final Categorization 25
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 24
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part II 23
PREVENTION OF AGE-RELATED COGNITIVE DECLINE BY LONG TERM AEROBIC TRAINING 22
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part I 20
Incidence and clinical implications of abstinence-induced hepatic recompensation in decompensated alcohol-related cirrhosis 19
Contrast-enhanced ultrasound liver imaging reporting and data system: Clinical validation in a prospective multinational study in North America and Europe 15
Totale 5.787
Categoria #
all - tutte 16.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021624 131 44 20 32 16 28 11 34 57 22 33 196
2021/2022858 74 23 40 44 78 48 23 48 34 46 251 149
2022/20231.085 116 164 68 162 59 79 31 57 165 21 81 82
2023/2024271 9 60 16 33 15 46 10 17 7 20 21 17
2024/20251.315 35 192 106 81 242 58 70 52 11 120 46 302
2025/202626 26 0 0 0 0 0 0 0 0 0 0 0
Totale 5.787